104 related articles for article (PubMed ID: 9927733)
1. Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents.
Cohen SB; Zheng G; Heyman HC; Stavnezer E
Nucleic Acids Res; 1999 Feb; 27(4):1006-14. PubMed ID: 9927733
[TBL] [Abstract][Full Text] [Related]
2. A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110.
Cohen SB; Nicol R; Stavnezer E
Oncogene; 1998 Nov; 17(19):2505-13. PubMed ID: 9824161
[TBL] [Abstract][Full Text] [Related]
3. A carboxyl-terminal region of the ski oncoprotein mediates homodimerization as well as heterodimerization with the related protein SnoN.
Heyman HC; Stavnezer E
J Biol Chem; 1994 Oct; 269(43):26996-7003. PubMed ID: 7929440
[TBL] [Abstract][Full Text] [Related]
4. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
5. Complex formation between proteins encoded by the ski gene family.
Nagase T; Nomura N; Ishii S
J Biol Chem; 1993 Jun; 268(18):13710-6. PubMed ID: 8514802
[TBL] [Abstract][Full Text] [Related]
6. Association of specific DNA binding and transcriptional repression with the transforming and myogenic activities of c-Ski.
Nicol R; Zheng G; Sutrave P; Foster DN; Stavnezer E
Cell Growth Differ; 1999 Apr; 10(4):243-54. PubMed ID: 10319994
[TBL] [Abstract][Full Text] [Related]
7. High affinity dimerization by Ski involves parallel pairing of a novel bipartite alpha-helical domain.
Zheng G; Blumenthal KM; Ji Y; Shardy DL; Cohen SB; Stavnezer E
J Biol Chem; 1997 Dec; 272(50):31855-64. PubMed ID: 9395532
[TBL] [Abstract][Full Text] [Related]
8. Ski and SnoN, potent negative regulators of TGF-beta signaling.
Deheuninck J; Luo K
Cell Res; 2009 Jan; 19(1):47-57. PubMed ID: 19114989
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Kidney Int; 2006 May; 69(10):1733-40. PubMed ID: 16625151
[TBL] [Abstract][Full Text] [Related]
10. Ski and SnoN: negative regulators of TGF-beta signaling.
Luo K
Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
[TBL] [Abstract][Full Text] [Related]
12. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
[TBL] [Abstract][Full Text] [Related]
13. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
Vignais ML
Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
[TBL] [Abstract][Full Text] [Related]
14. Are Ski and SnoN Involved in the Tumorigenesis of Oral Squamous Cell Carcinoma Through Smad4?
Alaeddini M; Etemad-Moghadam S
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):626-630. PubMed ID: 29734252
[TBL] [Abstract][Full Text] [Related]
15. Trans-regulation of myogenin promoter/enhancer activity by c-ski during skeletal-muscle differentiation: the C-terminus of the c-Ski protein is essential for transcriptional regulatory activity in myotubes.
Ichikawa K; Nagase T; Ishii S; Asano A; Mimura N
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):607-13. PubMed ID: 9371722
[TBL] [Abstract][Full Text] [Related]
16. SnoN co-repressor binds and represses smad7 gene promoter.
Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation.
Wrighton KH; Liang M; Bryan B; Luo K; Liu M; Feng XH; Lin X
J Biol Chem; 2007 Mar; 282(9):6517-24. PubMed ID: 17202138
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
Boone B; Haspeslagh M; Brochez L
J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site.
Nicol R; Stavnezer E
J Biol Chem; 1998 Feb; 273(6):3588-97. PubMed ID: 9452486
[TBL] [Abstract][Full Text] [Related]
20. DNA-binding and dimerization domains of adenosine 3',5'- cyclic monophosphate-responsive protein CREB reside in the carboxyl-terminal 66 amino acids.
Yun YD; Dumoulin M; Habener JF
Mol Endocrinol; 1990 Jun; 4(6):931-9. PubMed ID: 2146495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
